Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Oncology

Soft Tissue Sarcoma Clinical Trials

A listing of Soft Tissue Sarcoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35243

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Arizona

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of MM-310

Tucson Arizona

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

California

Stanford University Medical Center
Palo Alto California 94304

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Sarcoma Oncology Research Center
Santa Monica California 90403

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Duarte California 91010

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Los Angeles California 90033

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

UPDATED

San Francisco California 94115

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Santa Monica California 90404

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Santa Monica California 90403

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma

Colorado

University of Colorado Cancer Center
Aurora Colorado 80045

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Connecticut

New Haven Connecticut 06520

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

District of Columbia

MedStar Washington Hospital Center
Washington District of Columbia 20010

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Florida

Mayo Clinic of Jacksonville
Jacksonville Florida 32224

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

Jacksonville Florida 32224

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Jacksonville Florida 32224

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

UPDATED

Miami Florida 33136

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Miami Florida 33136

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Tampa Florida 33612

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

Georgia

Georgia Cancer Specialists
Sandy Springs Georgia 30342

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

Atlanta Georgia 30342

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Illinois

Northwestern University Feinburg School of Medicine
Chicago Illinois 60611

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Iowa

University of Iowa Hospital and Clinics
Iowa City Iowa 52242

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Iowa City Iowa

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Radiotherapy for the treatment of Soft Tissue Sarcoma

Kansas

Overland Park Kansas 66210

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

Maryland

UPDATED

Baltimore Maryland 21287

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Baltimore Maryland 21218

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

Boston Massachusetts 02215

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Michigan

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Detroit Michigan 48201

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Minnesota

Mayo Clinic Rochester
Rochester Minnesota 10029

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Rochester Minnesota 55905

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Missouri

Washington University in St. Louis
St. Louis Missouri 63110

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

St. Louis Missouri 63110

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

St. Louis Missouri 63110

A Phase 1 clinical study for patients with Soft Tissue Sarcoma

St. Louis Missouri 63130

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Nebraska

UPDATED

Omaha Nebraska 68114

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York

Tisch Cancer Institute
New York New York 10029

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Buffalo New York 92122

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

UPDATED

Lake Success New York 11042

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

New York New York 10065

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

New York New York 10032

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

North Carolina

Levine Cancer Institute
Charlotte North Carolina 28204

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Duke Cancer Institute
Durham North Carolina 27710

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Durham North Carolina 27710

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Huntersville North Carolina 28078

Patients are needed to participate in a clinical research study evaluating MGD009

Ohio

UPDATED

Cleveland Ohio 44195

A clinical trial seeking patients for a research study for the treatment of Ewing's Sarcoma

UPDATED

Columbus Ohio 43210

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced